LeafHans

LeafHans is a synthetic biology company headquartered in Shanghai that specializes in the microbial production of high-value natural products. The company utilizes a proprietary metabolic engineering platform to synthesize complex molecules such as cannabinoids and rare ginsenosides through yeast and bacterial fermentation. By bypassing traditional agricultural extraction, LeafHans provides a sustainable, high-purity, and scalable supply of ingredients for the pharmaceutical, nutraceutical, and skincare industries. Their portfolio includes bio-manufactured CBD, CBG, and various minor cannabinoids targeted at therapeutic areas such as neurology and dermatology. The company is positioned as a leader in the industrialization of synthetic biology for natural product synthesis in the Asian market.